Samantha Wadford
Psychiatric/Mental Health · Charleston, SCNPI 1588095988
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations.
Across 185 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$812
- Johnson & Johnson$587
- Alkermes, Inc.$356
- AbbVie$355
- Otsuka America Pharmaceutical, Inc.$352
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$339
- plus $1K from 9 others
What the payments were for
- Food & beverage$3,72897%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 41 | $812 |
| Johnson & Johnson | 30 | $587 |
| Alkermes, Inc. | 13 | $356 |
| AbbVie | 21 | $355 |
| Otsuka America Pharmaceutical, Inc. | 18 | $352 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $339 |
| Lundbeck LLC | 15 | $326 |
| Neurocrine Biosciences, Inc. | 8 | $202 |
| E.r. Squibb & Sons, L.L.C. | 8 | $167 |
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| Indivior Inc. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Novartis | 1 | $52 |
| Sunovion Pharmaceuticals Inc. | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$434
- ARISTADA INITIO$109
How this compares
$3,839 in reported general payments places this provider in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 186 | $595,320 |
| Invega TrinzaPaliperidone Palmitate | 56 | $439,413 |
| IngrezzaValbenazine Tosylate | 30 | $247,723 |
| AustedoDeutetrabenazine | 22 | $155,127 |
| Austedo XrDeutetrabenazine | 13 | $92,835 |
| Abilify MaintenaAripiprazole | 26 | $76,018 |
| Lurasidone Hcl | 79 | $46,741 |
| VraylarCariprazine Hcl | 29 | $43,989 |
| CaplytaLumateperone Tosylate | 12 | $23,094 |
| RexultiBrexpiprazole | 11 | $18,456 |
| Clozapine | 184 | $12,044 |
| Haloperidol Decanoate | 149 | $9,497 |
| Paliperidone ErPaliperidone | 66 | $6,328 |
| FetzimaLevomilnacipran Hcl | 11 | $6,289 |
| Aripiprazole | 93 | $6,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $587 | $1,034,733242 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $812 | $247,96335 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $202 | $247,72330 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $352 | $94,47437 claims |
| AbbVieVraylar, Fetzima, Saphris | $355 | $54,37751 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $339 | $23,09412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Charleston
- Cerrissa HugieCharleston$54K
- Lauren StephanCharleston$8K
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Karen FulwoodMyrtle Beach$30K
- Taylor CrewsIsle Of Palms$28K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- Mary McManusNorth Myrtle Beach$15K
- Kelsie FowlerAnderson$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.